Market Cap 6.98M
Revenue (ttm) 170,000.00
Net Income (ttm) -17.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,188.24%
Debt to Equity Ratio 0.00
Volume 33,903
Avg Vol 111,586
Day's Range N/A - N/A
Shares Out 2.71M
Stochastic %K 41%
Beta 1.03
Analysts Sell
Price Target $15.00

Company Profile

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 352 448 7797
Fax: 352 480 4620
Address:
2117 SW Highway 484, Ocala, United States
Momentumblitzzers
Momentumblitzzers Oct. 9 at 10:42 PM
Keep a close watch on CMCT! ITS MOVING!! $AIM $SVRE $ORLY $INUV !
0 · Reply
crown88
crown88 Oct. 9 at 7:03 PM
$AIM Starting to piss me off. It's been barcoding around 2.4-2.7 for 3 months now. either go up ur down
1 · Reply
uuddlrlr
uuddlrlr Oct. 9 at 11:41 AM
$AIM Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-025-07203-w.pdf
1 · Reply
Duncan74
Duncan74 Oct. 9 at 10:18 AM
$AIM $UPC Dilution? with $47,272,851 in cash??? If they would just mention “crypto” 😍
0 · Reply
Mansers
Mansers Oct. 9 at 10:05 AM
$UPC I say this from experience , pleased do not ignore the high likelihood of these types of companies tendency to hit a public offering when they get these spikes look at $AIM for example
0 · Reply
ultimatebastos
ultimatebastos Oct. 8 at 7:30 PM
$AIM he says no interest but he’s bashing 24/7
0 · Reply
ultimatebastos
ultimatebastos Oct. 8 at 3:32 PM
$AIM market makers ar dirty they support naked shorting. Every time aim goes up a little the mms halt aim so their beloved naked shorts can regroup for more damage
1 · Reply
uuddlrlr
uuddlrlr Oct. 7 at 11:02 AM
$AIM Over 2.5 years ago, CEO Equels explained why AIM was a company to watch (see clip below). Unfortunately for shareholders, the only thing shareholders watched was the stock value decrease by ~ 95% curtesy of incompetent leadership. https://x.com/aimimmuno/status/1628798240924598274?s=12&t=4ljN_nwhccGrZmMA3DUGPg CEO Equels should have been replaced years ago yet continues to collect a ridiculous compensation. Failure after failure the CEO still gets rewarded.
5 · Reply
uuddlrlr
uuddlrlr Oct. 6 at 8:29 PM
$AIM Shareholders continue to languish due to a weak AIM leadership team. Long time shareholders will never break even. What happened to the deceptive posters from 2023-2024 who defended CEO Equels and bashed the Kellner group at every opportunity? What happened to the deceptive posters who predicted billion dollars deals? What happened to the defenders of the reverse split? The best chance for AIM was the Kellner group 2024 which would have replaced the entire incompetent leadership team. Now shareholders have been diluted and the stock trades near all time lows. The only hope is pancreatic or ovarian cancer results and even if these are successful only new shareholders will actually profit. Terminate CEO Equels.
1 · Reply
lktrader
lktrader Oct. 6 at 6:29 PM
$AIM could use a $SPRB like run
1 · Reply
Latest News on AIM
AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Aug 21, 2025, 9:00 AM EDT - 7 weeks ago

AIM ImmunoTech Announces Release of the Next CEO Corner Segment


Why Is Micro-Cap AIM ImmunoTech Stock Surging?

Jul 28, 2025, 11:12 AM EDT - 2 months ago

Why Is Micro-Cap AIM ImmunoTech Stock Surging?


AIM ImmunoTech Resumes Trading on NYSE American

Jun 17, 2025, 8:55 AM EDT - 4 months ago

AIM ImmunoTech Resumes Trading on NYSE American


AIM ImmunoTech Announces 1-for-100 Reverse Stock Split

Jun 11, 2025, 4:15 PM EDT - 4 months ago

AIM ImmunoTech Announces 1-for-100 Reverse Stock Split


Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript

May 13, 2025, 9:54 AM EDT - 5 months ago

Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript


AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 9:19 AM EDT - 6 months ago

AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript


Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript

Mar 28, 2025, 11:39 AM EDT - 6 months ago

Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript


AIM's Clinical Strategy Under Incumbent Board Has Totally Failed

Dec 11, 2024, 7:30 AM EST - 10 months ago

AIM's Clinical Strategy Under Incumbent Board Has Totally Failed


AIM ImmunoTech Announces Cash Conservation Plan

Nov 27, 2024, 8:00 AM EST - 11 months ago

AIM ImmunoTech Announces Cash Conservation Plan


Momentumblitzzers
Momentumblitzzers Oct. 9 at 10:42 PM
Keep a close watch on CMCT! ITS MOVING!! $AIM $SVRE $ORLY $INUV !
0 · Reply
crown88
crown88 Oct. 9 at 7:03 PM
$AIM Starting to piss me off. It's been barcoding around 2.4-2.7 for 3 months now. either go up ur down
1 · Reply
uuddlrlr
uuddlrlr Oct. 9 at 11:41 AM
$AIM Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-025-07203-w.pdf
1 · Reply
Duncan74
Duncan74 Oct. 9 at 10:18 AM
$AIM $UPC Dilution? with $47,272,851 in cash??? If they would just mention “crypto” 😍
0 · Reply
Mansers
Mansers Oct. 9 at 10:05 AM
$UPC I say this from experience , pleased do not ignore the high likelihood of these types of companies tendency to hit a public offering when they get these spikes look at $AIM for example
0 · Reply
ultimatebastos
ultimatebastos Oct. 8 at 7:30 PM
$AIM he says no interest but he’s bashing 24/7
0 · Reply
ultimatebastos
ultimatebastos Oct. 8 at 3:32 PM
$AIM market makers ar dirty they support naked shorting. Every time aim goes up a little the mms halt aim so their beloved naked shorts can regroup for more damage
1 · Reply
uuddlrlr
uuddlrlr Oct. 7 at 11:02 AM
$AIM Over 2.5 years ago, CEO Equels explained why AIM was a company to watch (see clip below). Unfortunately for shareholders, the only thing shareholders watched was the stock value decrease by ~ 95% curtesy of incompetent leadership. https://x.com/aimimmuno/status/1628798240924598274?s=12&t=4ljN_nwhccGrZmMA3DUGPg CEO Equels should have been replaced years ago yet continues to collect a ridiculous compensation. Failure after failure the CEO still gets rewarded.
5 · Reply
uuddlrlr
uuddlrlr Oct. 6 at 8:29 PM
$AIM Shareholders continue to languish due to a weak AIM leadership team. Long time shareholders will never break even. What happened to the deceptive posters from 2023-2024 who defended CEO Equels and bashed the Kellner group at every opportunity? What happened to the deceptive posters who predicted billion dollars deals? What happened to the defenders of the reverse split? The best chance for AIM was the Kellner group 2024 which would have replaced the entire incompetent leadership team. Now shareholders have been diluted and the stock trades near all time lows. The only hope is pancreatic or ovarian cancer results and even if these are successful only new shareholders will actually profit. Terminate CEO Equels.
1 · Reply
lktrader
lktrader Oct. 6 at 6:29 PM
$AIM could use a $SPRB like run
1 · Reply
Teleboy
Teleboy Oct. 6 at 1:34 PM
$AIM Is the MTA referenced by Dr Kalinski (involving AIM, Merck, Roswell) new? This is a link to a screenshot of a slide from last week’s talk. I posted the original link last week for those who prefer the video. https://investorshub.advfn.com/uimage/uploads/2025/9/11/pagvkIMG_0856.jpeg
1 · Reply
ultimatebastos
ultimatebastos Oct. 5 at 7:16 AM
$AIM https://media4.giphy.com/media/WiyE4Wnh7T15IgGH2R/giphy.gif?cid=09f12532n2p1a2h72pqa0zba7bkw8gsuo364fx88xuzbwl3o&ep=v1_gifs_gifId&rid=giphy.gif&ct=g
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 7:32 PM
$AMZE $SST $ERNA $AIM Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 3 at 3:46 PM
$AIM Current Stock Price: $2.71 No options data available.
0 · Reply
anachartanalyst
anachartanalyst Oct. 3 at 11:01 AM
$AIM https://anachart.com/wp-content/uploads/ana_temp/1759489284_soc-img.jpg
0 · Reply
ultimatebastos
ultimatebastos Oct. 3 at 7:11 AM
$AIM Adam fraudstein the buddy of Croock Jim Cramer from the street are responsible for millions of deaths by slandering and shorting this company to where we are now.
1 · Reply
ultimatebastos
ultimatebastos Oct. 3 at 7:01 AM
$AIM yurkyurkson The croock from the yahoo board. I wonder what criminal organization he is representing.
0 · Reply
ultimatebastos
ultimatebastos Oct. 3 at 6:59 AM
$AIM the only ones to blame for this rediculous pps and the robbing of retail investors are the criminal shorters trying to destroy the company. Denying seriously sick people the best available treatment.
0 · Reply
Jubileespirit
Jubileespirit Oct. 3 at 2:38 AM
$AIM this company makes me nauseous. What a shame.
0 · Reply
Momentumblues
Momentumblues Oct. 3 at 12:42 AM
0 · Reply
jonjonson1234
jonjonson1234 Oct. 2 at 6:53 PM
$AIM Short Interest in the company is tiny and has been declining. Shares Outstanding 2.71M Float 2.59M % Held by Institutions 1.68% Shares Short (9/15/2025) 8.15k Shares Short (prior month 8/15/2025) 33.82k Short Ratio (9/15/2025) 0.16 Short % of Float (9/15/2025) 0.31% Short % of Shares Outstanding (9/15/2025) 0.30% It does not really make much sense to blame the share price on short selling. Of course, some posters here like to misread or misinterpret Reg SHO data, or pretend not to understand that the fresh new shares that the company is dumping at-the-market can show up on Reg SHO because of the mechanics of how the market makers make a market. But, if you look at the actual short interest, it is negligible.
1 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:37 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $EMPD $AIM $SVRE $ORLY 🔥
0 · Reply